Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder
Psilocybin-based treatment was also found to provide stronger returns in terms of the quality of life of patients following treatment, with psilocybin’s treatment returning a QALY nearly 10% larger than the next most effective treatment, CBT.
“We’re calling on health professionals and policymakers to seriously consider these findings which suggest psilocybin could be genuinely ground-breaking for the National Health Service and for the millions of people being treated for depression in the UK.”
Original Article (Medical News):
Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder
Artwork Fair Use: Simon Burchell
